Genmab A/S GENMAB ORD SHS | 2,684.0 / -1.58% |
Date/Time | 01/20 / 18:34 |
Chg. / Chg.(%) | -43.0 / -1.58% |
Bid | 2,602.0 / 2500 |
Ask | 2,735.0 / 2500 |
Open | 2,684.0 |
Previous Close | 2,727.0 |
High | 2,701.0 |
Low | 2,667.0 |
Volume [DKK] | 23,379,281.7 |
Volume [Units] | 9,144 |
Price fixings | 55 |
ISIN | DK0010272202 |
Security | 0MGB |
Exchange | London International |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
OMX Nordic | 2,676.00 | ![]() |
155,729 |
Cboe Europe .. | 2,676.00 | ![]() |
24,243 |
Turquoise | 2,682.00 | ![]() |
12,845 |
London Inter.. | 2,684.0 | ![]() |
9,144 |
Nasdaq Other.. | 440.5000 | ![]() |
650 |
Cboe Europe .. | 2,679.00 | ![]() |
377 |
TradeGate | 361.300 | ![]() |
359 |
Cboe Europe .. | 2,684.00 | ![]() |
100 |
München | 361.00 | ![]() |
92 |
gettex | 358.600 | ![]() |
43 |
Frankfurt | 361.9000 | ![]() |
8 |
Vienna Globa.. | 360.30 | ![]() |
0 |
Düsseldorf | 357.10 | ![]() |
0 |
Berlin | 358.80 | ![]() |
0 |
Stuttgart | 360.200 | ![]() |
0 |
Lang & Schwa.. | 361.20 | ![]() |
|
Mexico | 7,292.62 | ![]() |
111 |
News
- Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
01/20/2021 / 13:50 - GlobeNewswire - Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
01/15/2021 / 20:17 - GlobeNewswire - Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie
01/13/2021 / 15:20 - GlobeNewswire - An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
01/08/2021 / 11:45 - GlobeNewswire - BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
01/07/2021 / 20:15 - GlobeNewswire